Opportunity Information: Apply for RFA AG 19 018
The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required) is a National Institutes of Health funding opportunity administered through the National Institute on Aging (NIA). It is built to support early-stage physicians and other health professional investigators who are committed to aging research or aging-related diseases and who are ready to step into larger leadership roles in geriatrics and the broader aging research community. The intent is not only to develop the applicant as a stronger scientist, but also to accelerate their trajectory as a field leader whose work can influence scientific theory, clinical practice, and real-world health outcomes for older adults.
A defining feature of this K76 FOA is that it targets candidates who are already demonstrating independence compared with many other mentored career development (K) awards. Applicants are expected to have a track record of competitively awarded research support as a PD/PI at the faculty level, or to have otherwise leveraged faculty-level resources to build an independent line of research. In plain terms, this award is meant for people who have moved beyond the stage of simply training under someone else s grant and have started to show they can drive a research program. In addition, the FOA emphasizes evidence of leadership, whether that leadership has been demonstrated through clinical innovation, research direction, program building, or other forms of professional influence.
This specific version of the K76 is designed for applicants who will be the lead investigator of an independent clinical trial as part of their research and career development plan. That can include a full independent clinical trial, a clinical trial feasibility study, or a distinct ancillary study that is attached to an existing trial but remains a separate, clearly defined project. The independence requirement is central: the applicant is expected to be the person leading the trial effort, rather than participating in a trial run by another investigator simply to gain experience. If an applicant is not proposing an independent clinical trial, or if their plan is primarily to learn within a clinical trial led by someone else, the FOA directs them to apply instead to a companion announcement that fits non-independent trial scenarios.
From an eligibility standpoint, the opportunity is broadly open across many U.S.-based organizational types that commonly apply for NIH grants. Eligible applicants include public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (other than small businesses), small businesses, and multiple levels of government organizations (state, county, city or township, special districts, independent school districts), as well as public housing authorities and eligible tribal entities. The FOA also explicitly highlights a range of mission-focused and underserved-serving organizations as potential applicants, including Historically Black Colleges and Universities, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, along with faith-based or community-based organizations and certain regional organizations and U.S. territories or possessions. At the same time, the FOA places clear geographic and foreign involvement limits: non-U.S. (foreign) institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.
Administratively, this is a discretionary grant program in the health category, associated with CFDA 93.866 and run by NIH/NIA. The funding opportunity number is RFA-AG-19-018, and the original closing date listed in the source data is 2018-10-24, with a creation date of 2018-06-08. The source data also lists an award ceiling of 225,000. The FOA description does not specify additional details in the provided text about project period length, cost structure, or indirect cost treatment, but the ceiling indicates an upper cap for the award amount as represented in the opportunity listing.
Overall, the opportunity is best understood as a career development award for clinician-investigators and health professionals who are already emerging as independent researchers in aging and who want to pair structured career and leadership development with a significant, applicant-led clinical trial effort. The NIA s broader goal is to build the next generation of aging research leaders who can set agendas, run rigorous clinical research, and translate findings into improved care and outcomes for older adults.Apply for RFA AG 19 018
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-06-08.
- Applicants must submit their applications by 2018-10-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required)?
The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required) is a National Institutes of Health (NIH) funding opportunity administered through the National Institute on Aging (NIA). It is designed to support early-stage physicians and other health professional investigators who are committed to aging research or aging-related diseases and are preparing to take on larger leadership roles in geriatrics and the broader aging research community.
Which NIH Institute administers this opportunity?
This funding opportunity is administered by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).
What is the main purpose of this award?
The award is intended to develop the applicant as a stronger scientist while also accelerating their trajectory as a leader in the aging research field. The aim is to support work that can influence scientific theory, clinical practice, and real-world health outcomes for older adults.
Who is this K76 opportunity intended for?
It targets early-stage physicians and other health professional investigators who are committed to aging research or aging-related diseases and who are already demonstrating independence beyond many other mentored career development (K) awards.
What does "Emerging Leaders" mean in the context of this FOA?
Based on the provided description, "Emerging Leaders" refers to candidates who are not only progressing scientifically, but who also show evidence of leadership through activities such as clinical innovation, research direction, program building, or other forms of professional influence.
How is this K76 different from many other mentored K awards?
A defining feature is the expectation of greater independence. Applicants are expected to have a track record of competitively awarded research support as a PD/PI at the faculty level, or to have leveraged faculty-level resources to build an independent line of research, rather than primarily training under another investigator's grant.
Does this specific K76 require a clinical trial?
Yes. This version is specifically designed for applicants who will be the lead investigator of an independent clinical trial as part of their research and career development plan.
What kinds of clinical trial activities can be included?
The clinical trial component can include a full independent clinical trial, a clinical trial feasibility study, or a distinct ancillary study attached to an existing trial, as long as it remains a separate, clearly defined project.
What does "independent clinical trial" mean for this FOA?
Independence is central. The applicant is expected to lead the trial effort, rather than participate in a trial run by another investigator primarily to gain experience.
What if an applicant is not proposing an independent clinical trial?
If an applicant is not proposing an independent clinical trial, or if their plan is primarily to learn within a clinical trial led by someone else, the FOA directs them to apply to a companion announcement that fits non-independent trial scenarios.
What research areas does this award focus on?
The focus is on aging research and aging-related diseases, with an emphasis on generating findings that can translate into improved care and outcomes for older adults.
What types of applicants (organizations) are eligible to apply?
The opportunity is broadly open to many U.S.-based organization types that commonly apply for NIH grants, including:
- Public and private institutions of higher education
- Nonprofits, including 501(c)(3) and non-501(c)(3) entities
- For-profit organizations (other than small businesses)
- Small businesses
- State, county, city or township government entities
- Special districts
- Independent school districts
- Public housing authorities
- Eligible tribal entities
Are minority-serving institutions and community-based organizations highlighted as potential applicants?
Yes. The FOA explicitly highlights mission-focused and underserved-serving organizations as potential applicants, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, as well as faith-based or community-based organizations and certain regional organizations and U.S. territories or possessions.
Are foreign (non-U.S.) institutions eligible to apply?
No. Non-U.S. (foreign) institutions are not eligible to apply.
Are non-domestic components of U.S. organizations eligible?
No. Non-domestic components of U.S. organizations are not eligible.
Are foreign components allowed under NIH policy for this opportunity?
No. Foreign components (as defined by NIH policy) are not allowed.
What type of grant program is this described as?
The listing describes it as a discretionary grant program in the health category.
What is the Funding Opportunity Announcement (FOA) number?
The funding opportunity number is RFA-AG-19-018.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.866.
What is the listed award ceiling for this opportunity?
The source data lists an award ceiling of 225,000.
Does the provided description specify the project period, cost structure, or indirect cost treatment?
No. The provided text does not specify additional details about project period length, cost structure, or indirect cost treatment. It only notes the award ceiling as represented in the opportunity listing.
What are the key candidate expectations described in the opportunity?
The description emphasizes candidates who have moved beyond primarily training under another investigator and have begun to demonstrate they can drive a research program. It also emphasizes evidence of leadership and a plan that includes an applicant-led independent clinical trial.
What outcomes is NIA trying to advance through this award?
NIA's stated goal is to build the next generation of aging research leaders who can set agendas, run rigorous clinical research, and translate findings into improved care and outcomes for older adults.
What is the original closing date and the creation date listed in the source data?
The original closing date listed is 2018-10-24, and the creation date listed is 2018-06-08.
Browse more opportunities from the same category: Health
Next opportunity: Notice of Intent: Cooperative Monitoring and Assessment of Hawaii Volcano Hazards
Previous opportunity: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 19 018
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 19 018) also looked into and applied for these:
| Funding Opportunity |
|---|
| Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed) Apply for PA 18 823 Funding Number: PA 18 823 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) Apply for RFA TR 18 021 Funding Number: RFA TR 18 021 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional) Apply for RFA AI 18 006 Funding Number: RFA AI 18 006 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 18 828 Funding Number: PAR 18 828 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Apply for PAR 18 829 Funding Number: PAR 18 829 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Orphans and Vulnerable Children II (OVC II) Activity Apply for 72052118R00016 Funding Number: 72052118R00016 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: $19,950,000 |
| Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) Apply for PAR 18 833 Funding Number: PAR 18 833 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) Apply for PAR 18 832 Funding Number: PAR 18 832 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed) Apply for RFA AI 18 026 Funding Number: RFA AI 18 026 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed) Apply for RFA AG 19 016 Funding Number: RFA AG 19 016 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed) Apply for RFA AG 19 015 Funding Number: RFA AG 19 015 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) Apply for PAR 18 840 Funding Number: PAR 18 840 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required) Apply for RFA AI 18 022 Funding Number: RFA AI 18 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed) Apply for RFA AI 18 025 Funding Number: RFA AI 18 025 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 18 844 Funding Number: PAR 18 844 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) Apply for PAR 18 843 Funding Number: PAR 18 843 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 037 Funding Number: RFA AI 18 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional) Apply for RFA DC 19 001 Funding Number: RFA DC 19 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Required) Apply for RFA MH 19 101 Funding Number: RFA MH 19 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Not Allowed) Apply for RFA MH 19 100 Funding Number: RFA MH 19 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 19 018", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.